C07C 275/16
Being further substituted by carboxyl groups
Official title: being further substituted by carboxyl groups
C07C275/16 (Being further substituted by carboxyl groups) appears on 239 US grants and 232 published applications in this corpus.
Search patents in C07C- Granted patents
- 239
- Published applications
- 232
- Assignees
- 131
- Inventors
- 601
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 16 | 0 |
| 1997 | 18 | 0 |
| 1998 | 8 | 0 |
| 1999 | 6 | 0 |
| 2000 | 8 | 0 |
| 2001 | 7 | 0 |
| 2002 | 5 | 8 |
| 2003 | 6 | 6 |
| 2004 | 2 | 4 |
| 2005 | 2 | 3 |
| 2006 | 5 | 4 |
| 2007 | 2 | 2 |
| 2008 | 2 | 8 |
| 2009 | 0 | 11 |
| 2010 | 4 | 7 |
| 2011 | 5 | 7 |
| 2012 | 9 | 8 |
| 2013 | 9 | 5 |
| 2014 | 6 | 6 |
| 2015 | 9 | 4 |
| 2016 | 7 | 9 |
| 2017 | 2 | 9 |
| 2018 | 8 | 7 |
| 2019 | 11 | 12 |
| 2020 | 10 | 10 |
| 2021 | 7 | 8 |
| 2022 | 5 | 7 |
| 2023 | 5 | 15 |
| 2024 | 5 | 7 |
| 2025 | 10 | 13 |
| 2026 | 11 | 52 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Amino acid compositions22 Sep 2026US 12,741,941 B2ThermoLife International, LLC
- Ionizable cationic lipids for RNA delivery1 Sep 2026US 12,723,023 B2Arcturus Therapeutics, Inc.
- 18F-labeled triazole containing PSMA inhibitors14 Jul 2026US 12,679,812 B2Cornell University
- Amino acid compositions28 Apr 2026US 12,612,370 B2ThermoLife International, LLC
- Calpain-2 inhibitor compounds and methods of treatment21 Apr 2026US 12,606,520 B2Western University of Health Sciences
- Amino acid compositions23 Jul 2026US 2026/0209184 A1ThermoLife International, LLC
- Amino acid compositions16 Jul 2026US 2026/0200858 A1ThermoLife International, LLC
- Amino acid compositions16 Jul 2026US 2026/0200859 A1ThermoLife International, LLC
- Amino acid compositions16 Jul 2026US 2026/0200860 A1ThermoLife International, LLC
- Amino acid compositions16 Jul 2026US 2026/0200861 A1ThermoLife International, LLC
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Ligands for metabotropic glutamate receptors and inhibitors of NAALADase119US 6,528,499 B1Georgetown University · 2003
- Cancer cell targeting using nanoparticles115US 8,603,501 B2BIND Therapeutics, Inc. · 2013
- Cancer cell targeting using nanoparticles113US 8,603,499 B2BIND Therapeutics, Inc. · 2013
- Cancer cell targeting using nanoparticles113US 8,603,500 B2BIND Therapeutics, Inc. · 2013